Successful treatment of pyoderma gangrenosum with intravenous immunoglobulins during pregnancy

Journal of Cutaneous Medicine and Surgery

Volumn 16, Issue 3, 2012, Pages 205-207

  Erfurt Berge, Cornelia ^a   Herbst, Christine ^a   Schuler, Gerold ^a   Bauerschmitz, Juergen ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GESTATION PERIOD; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LEG ULCER; MULTIPLE CYCLE TREATMENT; NEWBORN; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; RECURRENT DISEASE; RETREATMENT; SKIN EXAMINATION; SKIN INFLAMMATION; SKIN ULCER; TREATMENT RESPONSE; TWIN PREGNANCY;

ADULT; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PREGNANCY; PREGNANCY COMPLICATIONS; PYODERMA GANGRENOSUM;

EID: 84864220720     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347541201600314     Document Type: Article

References (10)

1. Powell FC, Collins S. Pyoderma gangrenosum. Clin Dermatol 2000;18:283-93, doi:10.1016/S0738-081X(99)00119-4.
2. Aytekin S, Tarlan N, Kalkanli N, et al. Pyoderma gangrenosum in pregnancy. J Eur Acad Dermatol Venereol 2002;16:546-8, doi:10.1046/j.1468-3083. 2002.00476-12.x.
3. Gorpelioglu C, Sarifakioglu E, Ayrim A. Pyoderma gangrenosum in pregnancy. Eur J Dermatol 2009;19:528-9.
4. Reddy K, Brightman L, Venna S. Pyoderma gangrenosum with pathergy in a pregnant patient without associated systemic disease. Cutis 2008;81:255-8.
5. Futami H, Kodaira M, Furuta T, et al. Pyoderma gangrenosum complicating ulcerative colitis: successful treatment with methylprednisolone pulse therapy and cyclosporine. J Gastroenterol 1998;33:408-11, doi:10.1007/s005350050104. (Pubitemid 28263658)
6. Oka M, Berking C, Nesbit M, et al. Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts. Lab Invest 2000;80:595-604. (Pubitemid 30226640)
7. Shimoya K, Moriyama A, Matsuzaki N, et al. Human placental cells show enhanced production of interleukin (IL)-8 in response to lipopolysaccharide (LPS), IL-1 and tumour necrosis factor (TNF)-alpha, but not to IL-6. Mol Hum Reprod 1999;5:885, doi:10.1093/molehr/5.9.885.
8. Miller J, Yentzer BA, Clark A, et al. Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol 2010;62:646-54, doi:10.1016/j.jaad. 2009.05.030.
9. Cummins DL, Anhalt GJ, Monahan T, Meyerle JH. Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol 2007;157:1235-9, doi:10.1111/j.1365-2133.2007.08217.x. (Pubitemid 350115690)
10. Kreuter A, Reich-Schupke S, Stucker M, et al. Intravenous immunoglobulin for pyoderma gangrenosum. Br J Dermatol 2008;158:856-7, doi:10.1111/j.1365-2133. 2007.08433.x. (Pubitemid 351415737)